The miR-340-5p, which is downregulated in cisplatin-resistant osteosarcoma cell lines, targets the 3′ UTR of AGPAT2 and, although it does not affect mRNA levels, decreases the levels of AGPAT2 protein [66]. Here, AGPAT2 is linked to osteosarcoma.